Mainline Biosciences (China) Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A1

  • Investors
  • 3

Mainline Biosciences (China) General Information

Description

Developer of novel peptide drugs designed for oncology treatment. The company focuses on the field of innovative peptide drugs through computational chemistry and AI-assisted peptide design, providing patients with innovative treatment drugs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 409, 4th Floor, Building C, Innovation Center
  • No. 34 Xiangshan Avenue, Cuiheng New District
  • Zhongshan, Guangdong 528449
  • China
+86 131
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Room 409, 4th Floor, Building C, Innovation Center
  • No. 34 Xiangshan Avenue, Cuiheng New District
  • Zhongshan, Guangdong 528449
  • China
+86 131

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mainline Biosciences (China) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A1) 21-Jul-2024 Completed Clinical Trials - General
1. Early Stage VC (Series A) 09-Nov-2022 Completed Clinical Trials - General
To view Mainline Biosciences (China)’s complete valuation and funding history, request access »

Mainline Biosciences (China) Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Taikun Fund Venture Capital Minority
Fuho Capital Venture Capital Minority
SAFE Pharmaceutical VC-Backed Company Minority
To view Mainline Biosciences (China)’s complete investors history, request access »

Mainline Biosciences (China) FAQs

  • When was Mainline Biosciences (China) founded?

    Mainline Biosciences (China) was founded in 2021.

  • Where is Mainline Biosciences (China) headquartered?

    Mainline Biosciences (China) is headquartered in Zhongshan, China.

  • What industry is Mainline Biosciences (China) in?

    Mainline Biosciences (China)’s primary industry is Drug Discovery.

  • Is Mainline Biosciences (China) a private or public company?

    Mainline Biosciences (China) is a Private company.

  • What is Mainline Biosciences (China)’s current revenue?

    The current revenue for Mainline Biosciences (China) is .

  • How much funding has Mainline Biosciences (China) raised over time?

    Mainline Biosciences (China) has raised $13.8M.

  • Who are Mainline Biosciences (China)’s investors?

    Taikun Fund, Fuho Capital, and SAFE Pharmaceutical have invested in Mainline Biosciences (China).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process